New numbing drug could ease pain after lung surgery

NCT ID NCT07432711

First seen Jun 25, 2026 · Last updated Jul 15, 2026 · Updated 3 times

Summary

This study tests whether a long-acting numbing drug called liposomal bupivacaine, when added to a standard painkiller, provides better pain relief after video-assisted lung surgery. About 100 adults having lung surgery will receive either the combination or the standard drug alone. The goal is to see if the new approach reduces the need for rescue pain medication and improves recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
liposomal bupivacaine plus bupivacaine hydrochloride
What this could lead to
If it works, this could provide longer-lasting pain relief after lung surgery, reducing the need for strong painkillers and possibly lowering the risk of chronic pain.
What could go wrong
This is a small, early-phase trial with only 100 participants, so results may not apply to everyone. The benefit over standard care is uncertain, and there is always a risk of side effects like allergic reactions or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIPOSOMAL BUPIVACAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Tiantan Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100070, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.